Re: 50/50 at best on Zen being sold this year IMO..

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

dutchfella

Rank: Mail Room [?]

Points: 141 [?]

Votes: 15 Score: 2.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 50/50 at best on Zen being sold this year IMO..

in response to

Re: 50/50 at best on Zen being sold this year IMO..

fuzzyjr

posted on May 13, 2020 03:53PM

you were whining about not knowing anything and not being able to sell your shares. I offerred you some thoughts and the possibility of a sale and now you want to set the terms of my offer and complain? No problem, keep your shares and your misery and put me on ignore.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply